ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
pal85a
|
103 |
29K |
20 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
29K
|
20
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
pal85a
|
103 |
29K |
10 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
29K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
pal85a
|
103 |
29K |
9 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
29K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
pal85a
|
103 |
29K |
15 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
29K
|
15
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Gets Ethics Approval To Start Phase 1 Intravenous Clinical Trial
|
|
pal85a
|
43 |
12K |
2 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
43
|
12K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Gets Ethics Approval To Start Phase 1 Intravenous Clinical Trial
|
|
pal85a
|
43 |
12K |
6 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
43
|
12K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening R&D Address at World AMR Congress
|
|
pal85a
|
9 |
2.9K |
5 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
9
|
2.9K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening R&D Address at World AMR Congress
|
|
pal85a
|
9 |
2.9K |
5 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
9
|
2.9K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening R&D Address at World AMR Congress
|
|
pal85a
|
9 |
2.9K |
11 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
9
|
2.9K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4C and Activity Report
|
|
pal85a
|
8 |
2.7K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4C and Activity Report
|
|
pal85a
|
8 |
2.7K |
3 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
8
|
2.7K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
VIDEO: Recce Pharmaceuticals (ASX:RCE) receives ethics approval to begin R327 trial
|
|
pal85a
|
11 |
3.5K |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
11
|
3.5K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial
|
|
pal85a
|
29 |
8.3K |
2 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
29
|
8.3K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial
|
|
pal85a
|
29 |
8.3K |
4 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
29
|
8.3K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial
|
|
pal85a
|
29 |
8.3K |
7 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
29
|
8.3K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
5 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
5
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
0 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Suspension from Official Quotation
|
|
pal85a
|
17 |
4.4K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
17
|
4.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Suspension from Official Quotation
|
|
pal85a
|
17 |
4.4K |
1 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
17
|
4.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Suspension from Official Quotation
|
|
pal85a
|
17 |
4.4K |
0 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
17
|
4.4K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Suspension from Official Quotation
|
|
pal85a
|
17 |
4.4K |
0 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
17
|
4.4K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Suspension from Official Quotation
|
|
pal85a
|
17 |
4.4K |
1 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
17
|
4.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Court application and delayed cleansing notice
|
|
pal85a
|
32 |
9.4K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
32
|
9.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Court application and delayed cleansing notice
|
|
pal85a
|
32 |
9.4K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
32
|
9.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading halt
|
|
pal85a
|
20 |
6.3K |
2 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
20
|
6.3K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading halt
|
|
pal85a
|
20 |
6.3K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
20
|
6.3K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
pal85a
|
23 |
5.7K |
1 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
pal85a
|
23 |
5.7K |
5 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
pal85a
|
23 |
5.7K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
pal85a
|
23 |
5.7K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Pause in Trading
|
|
pal85a
|
23 |
5.7K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
23
|
5.7K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
4 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
2.1K
|
625K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
4 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
4 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
3 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
2 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
2
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
3 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
7 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
3 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
5 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
5
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
1 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
2.1K
|
625K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
6 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
2.1K
|
625K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Anti-Viral Patent Granted in China
|
|
pal85a
|
55 |
15K |
6 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
55
|
15K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Receives Further Innovation Connections Grant
|
|
pal85a
|
36 |
8.9K |
15 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
36
|
8.9K
|
15
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
pal85a
|
2.1K |
625K |
2 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
2.1K
|
625K
|
2
|
|